Early results from a study examining a rare type of Alzheimer’s offer the first hope of prevention and treatment trials in this group and may ultimately have implications for the most common AD form. Medscape Medical News
No Comments »
Filed under: General Health News
A study shows that deaths from chickenpox have dropped 88% since the vaccine program began in U.S. WebMD Health News
No Comments »
Filed under: General Health News
The controversy continues on the association between mobile phone use and brain tumors. Are gliomas in cell phone users preferentially located in areas of the brain with the highest RF exposure? American Journal of Epidemiology
No Comments »
Filed under: General Health News
Minority participation in clinical trials remains lower than in the general population, accounting for only 10% of participants in multicenter clinical trials. Medscape Medical News
No Comments »
Filed under: General Health News
(MedPage Today) — An FDA advisory committee has recommended in favor of a humanitarian exemption for Berlin Heart’s EXCOR ventricular assist device for use in children as a bridge to heart transplant.
No Comments »
Filed under: General Health News
(MedPage Today) — Tools designed to predict mortality may not forecast a patient’s demise very accurately, researchers have found.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — FDA Commissioner Margaret Hamburg, MD, addressed on Monday the “increasing drumbeat” of criticism suggesting that the agency is slowing innovation by requiring drug and device companies to wait excessively long periods for approval.
No Comments »
Filed under: General Health News
Selexis SA, a global life science company with technologies for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins announced today that CSL Limited has entered a commercial license agreement with Selexis for the preclinical development of a therapeutic antibody anticipated to enter Phase I clinical trials in 2012.
No Comments »
Filed under: Pharmacy News
Biogen Idec and Swedish Orphan Biovitrum today announced Phase 1/2a trial data showing that the companies’ long-lasting fully-recombinant factor VIII Fc fusion protein (rFVIIIFc) was well tolerated and demonstrated an approximately 1.7-fold increase in half-life compared with Advate, a commercially-available factor VIII product, in 16 previously-treated patients with severe hemophilia A.
No Comments »
Filed under: Pharmacy News
Depending on the total dosage of zinc and the composition of lozenges, zinc lozenges may shorten the duration of common cold episodes by up to 40%, according to a study published in the Open Respiratory Medicine Journal.
No Comments »
Filed under: Pharmacy News
